
Soligenix Advances CTCL Treatment with HyBryte FLASH Study Results
Soligenix is strengthening its position in cutaneous T-cell lymphoma treatment through pivotal clinical trials demonstrating HyBryte's efficacy and ongoing confirmatory studies supporting potential regulatory approvals worldwide.
Read full story

























